Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.

At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.


Latest News

NeuroTronik Announces $23.1 Million Series B Preferred Stock Financing

April 18, 2017

Funding to advance NeuroTronik CANS TherapyTM to improve the treatment of Acute Heart Failure in the Hospital Pre-clinical and clinical experience has been highly-encouraging as to the promise of theā€¦

More News